Skip to content
HCN Grants Est. 2026
No. HT942526OCRPPA · Defense Health Agency Contracting Activity - DHACA
Open

DoW, Ovarian Cancer, Pilot Award

grants.gov listing ↗ Full announcement (NOFO) ↗
Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Invitation only
“full application submission is by invitation only.” — From the announcement

At a glance

The Ovarian Cancer Research Program offers several awards for research on ovarian cancer, including clinical trials, investigator-led research, early-career academy awards, and a pilot award. Eligibility ranges from postdoctoral or clinical fellows for the Pilot Award to assistant professor level and above for the Investigator-Initiated Research Award, with early-career awards limited to investigators within 5 or 12 years of postdoctoral or fellowship training. Award amounts and periods vary: the Pilot Award allows up to $350,000 for 2 years, the Clinical Trial Award up to $2.8 million for 4 years, the Investigator-Initiated Research Award up to $1.05 million for a single PI or $1.40 million for partnering PIs over 4 years, the Early-Career Investigator Award up to $1.125 million for 4 years, and the Clinical Trial Academy Early-Career Investigator Award up to $1.4 million for 4 years. Some awards require preliminary data, some do not allow clinical trials, and several require a letter of intent or preproposal before full application; the notice does not state any geographic restrictions or cost-share requirements.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Patients & People with Health Conditions
  • Biomedical & Disease Research
Official description from grants.gov

Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism. This mechanism includes a blinded pre-application component. Pre-applications to this funding opportunity will undergo a blinded pre-application screening. While preparing your pre-application, do not include any material that may identify the PI, a collaborator, or the organization of the PI or collaborator.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide